A Study to investigate immunogenic potential of Precision Immune Stimulants-2 (PIN-2) in Patients with Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumors
- Registration Number
- ACTRN12617001597381
- Lead Sponsor
- PIN Pharma Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method